- Home
- CXAI vs ACXP Comparison
CXAI vs ACXP Comparison
Compare CXAI & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CXAI
- ACXP
- Stock Information
- Founded
- CXAI N/A
- ACXP 2017
- Country
- CXAI United States
- ACXP United States
- Employees
- CXAI N/A
- ACXP N/A
- Industry
- CXAI EDP Services
- ACXP Biotechnology: Pharmaceutical Preparations
- Sector
- CXAI Technology
- ACXP Health Care
- Exchange
- CXAI Nasdaq
- ACXP Nasdaq
- Market Cap
- CXAI 22.4M
- ACXP 8.4M
- IPO Year
- CXAI N/A
- ACXP 2021
- Fundamental
- Price
- CXAI $0.97
- ACXP $0.43
- Analyst Decision
- CXAI
- ACXP Strong Buy
- Analyst Count
- CXAI 0
- ACXP 2
- Target Price
- CXAI N/A
- ACXP $10.00
- AVG Volume (30 Days)
- CXAI 483.1K
- ACXP 18.7M
- Earning Date
- CXAI 08-11-2025
- ACXP 08-08-2025
- Dividend Yield
- CXAI N/A
- ACXP N/A
- EPS Growth
- CXAI N/A
- ACXP N/A
- EPS
- CXAI N/A
- ACXP N/A
- Revenue
- CXAI $6,548,000.00
- ACXP N/A
- Revenue This Year
- CXAI N/A
- ACXP N/A
- Revenue Next Year
- CXAI $60.00
- ACXP N/A
- P/E Ratio
- CXAI N/A
- ACXP N/A
- Revenue Growth
- CXAI N/A
- ACXP N/A
- 52 Week Low
- CXAI $0.76
- ACXP $0.30
- 52 Week High
- CXAI $3.76
- ACXP $3.33
- Technical
- Relative Strength Index (RSI)
- CXAI 48.92
- ACXP 46.13
- Support Level
- CXAI $0.97
- ACXP $0.45
- Resistance Level
- CXAI $1.03
- ACXP $0.59
- Average True Range (ATR)
- CXAI 0.06
- ACXP 0.07
- MACD
- CXAI 0.01
- ACXP -0.01
- Stochastic Oscillator
- CXAI 48.78
- ACXP 10.73
About CXAI CXApp Inc.
CXApp Inc is a provider of AI-powered employee experience solutions, delivering enterprise-grade software that enhances workplace engagement, productivity, and operational efficiency. The company's flagship product, the CXAI Platform, provides a comprehensive suite of tools designed to empower employees and enable organizations to create smarter workplaces. The product's key components include CXAI Apps, CXAI BTS, and CXAI-VU. The company generates the majority of its revenue from Licenses.
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.